These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 22983262)

  • 1. Novel target genes and a valid biomarker panel identified for cholangiocarcinoma.
    Andresen K; Boberg KM; Vedeld HM; Honne H; Hektoen M; Wadsworth CA; Clausen OP; Karlsen TH; Foss A; Mathisen O; Schrumpf E; Lothe RA; Lind GE
    Epigenetics; 2012 Nov; 7(11):1249-57. PubMed ID: 22983262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The novel colorectal cancer biomarkers CDO1, ZSCAN18 and ZNF331 are frequently methylated across gastrointestinal cancers.
    Vedeld HM; Andresen K; Eilertsen IA; Nesbakken A; Seruca R; Gladhaug IP; Thiis-Evensen E; Rognum TO; Boberg KM; Lind GE
    Int J Cancer; 2015 Feb; 136(4):844-53. PubMed ID: 24948044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global alterations of DNA methylation in cholangiocarcinoma target the Wnt signaling pathway.
    Goeppert B; Konermann C; Schmidt CR; Bogatyrova O; Geiselhart L; Ernst C; Gu L; Becker N; Zucknick M; Mehrabi A; Hafezi M; Klauschen F; Stenzinger A; Warth A; Breuhahn K; Renner M; Weichert W; Schirmacher P; Plass C; Weichenhan D
    Hepatology; 2014 Feb; 59(2):544-54. PubMed ID: 24002901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methyl-CpG binding protein MBD2 is implicated in methylation-mediated suppression of miR-373 in hilar cholangiocarcinoma.
    Chen Y; Gao W; Luo J; Tian R; Sun H; Zou S
    Oncol Rep; 2011 Feb; 25(2):443-51. PubMed ID: 21165562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylation profiles of multiple CpG island loci in extrahepatic cholangiocarcinoma versus those of intrahepatic cholangiocarcinomas.
    Kim BH; Cho NY; Choi M; Lee S; Jang JJ; Kang GH
    Arch Pathol Lab Med; 2007 Jun; 131(6):923-30. PubMed ID: 17550320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant promoter CpG islands methylation of tumor suppressor genes in cholangiocarcinoma.
    Uhm KO; Lee ES; Lee YM; Kim HS; Park YN; Park SH
    Oncol Res; 2008; 17(4):151-7. PubMed ID: 18773859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Four DNA methylation biomarkers in biliary brush samples accurately identify the presence of cholangiocarcinoma.
    Andresen K; Boberg KM; Vedeld HM; Honne H; Jebsen P; Hektoen M; Wadsworth CA; Clausen OP; Lundin KE; Paulsen V; Foss A; Mathisen Ø; Aabakken L; Schrumpf E; Lothe RA; Lind GE
    Hepatology; 2015 May; 61(5):1651-9. PubMed ID: 25644509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DLEC1 methylation is associated with a better clinical outcome in patients with intrahepatic cholangiocarcinoma of the small duct subtype.
    Kim Y; Lee K; Jeong S; Wen X; Cho NY; Kang GH
    Virchows Arch; 2019 Jul; 475(1):49-58. PubMed ID: 30610381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant CpG island methylation of multiple genes in intrahepatic cholangiocarcinoma.
    Lee S; Kim WH; Jung HY; Yang MH; Kang GH
    Am J Pathol; 2002 Sep; 161(3):1015-22. PubMed ID: 12213730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promoter hypermethylation of death-associated protein kinase gene in cholangiocarcinoma.
    Liu XF; Kong FM; Xu Z; Yu SP; Sun FB; Zhang CS; Huang QX; Zhou XT; Song ZW
    Hepatobiliary Pancreat Dis Int; 2007 Aug; 6(4):407-11. PubMed ID: 17690039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma.
    Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B
    World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant methylation of HTATIP2 and UCHL1 as a predictive biomarker for cholangiocarcinoma.
    Nanok C; Jearanaikoon P; Proungvitaya S; Limpaiboon T
    Mol Med Rep; 2018 Mar; 17(3):4145-4153. PubMed ID: 29359783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of epigenetic alterations in cholangiocarcinoma.
    Tischoff I; Wittekind C; Tannapfel A
    J Hepatobiliary Pancreat Surg; 2006; 13(4):274-9. PubMed ID: 16858537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant DNA methylation at genes associated with a stem cell-like phenotype in cholangiocarcinoma tumors.
    Sriraksa R; Zeller C; Dai W; Siddiq A; Walley AJ; Limpaiboon T; Brown R
    Cancer Prev Res (Phila); 2013 Dec; 6(12):1348-55. PubMed ID: 24089088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promoter methylation profiles of tumor suppressor genes in intrahepatic and extrahepatic cholangiocarcinoma.
    Yang B; House MG; Guo M; Herman JG; Clark DP
    Mod Pathol; 2005 Mar; 18(3):412-20. PubMed ID: 15467712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant DNA methylation of integrin alpha4: a potential novel role for metastasis of cholangiocarcinoma.
    Uhm KO; Lee JO; Lee YM; Lee ES; Kim HS; Park SH
    J Cancer Res Clin Oncol; 2010 Feb; 136(2):187-94. PubMed ID: 19655168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between promoter methylation of p14(ARF), TMS1/ASC, and DAPK, and p53 mutation with prognosis in cholangiocarcinoma.
    Xiaofang L; Kun T; Shaoping Y; Zaiqiu W; Hailong S
    World J Surg Oncol; 2012 Jan; 10():5. PubMed ID: 22230750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of methylation profile of HOX genes in extrahepatic cholangiocarcinoma.
    Shu Y; Wang B; Wang J; Wang JM; Zou SQ
    World J Gastroenterol; 2011 Aug; 17(29):3407-19. PubMed ID: 21876633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DCLK1, a Putative Stem Cell Marker in Human Cholangiocarcinoma.
    Nevi L; Di Matteo S; Carpino G; Zizzari IG; Samira S; Ambrosino V; Costantini D; Overi D; Giancotti A; Monti M; Bosco D; De Peppo V; Oddi A; De Rose AM; Melandro F; Bragazzi MC; Faccioli J; Massironi S; Grazi GL; Panici PB; Berloco PB; Giuliante F; Cardinale V; Invernizzi P; Caretti G; Gaudio E; Alvaro D
    Hepatology; 2021 Jan; 73(1):144-159. PubMed ID: 32978808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of MGMT promotes proliferation of intrahepatic cholangiocarcinoma by regulating p21.
    Chen J; Li Z; Chen J; Du Y; Song W; Xuan Z; Zhao L; Song G; Song P; Zheng S
    Clin Transl Oncol; 2020 Mar; 22(3):392-400. PubMed ID: 31264147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.